Contact this trialFirst, we need to learn more about you.
CAR T-cell Therapy
CTX131 for Resistant or Recurrent Cancer
Recruiting1 awardPhase 1 & 2
Chicago, Illinois
This trial is testing CTX131, a treatment that uses modified immune cells to fight cancer, in patients whose cancer has come back or didn't respond to other treatments. The immune cells are changed using gene-editing technology to help them attack the cancer.
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service.
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.
By clicking start, you agree to our
terms of service